Thomas M. Polasek

First-in-human single-dose study of nizubaglustat, a dual inhibitor of ceramide glucosyltransferase and non-lysosomal glucosylceramidase: Safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending and multiple doses in healthy adults.

Cecile Paquet Luzy, Emilie Doppler, Thomas M. Polasek, 2023, Molecular genetics and metabolism.

Efficacy and safety of pharmacogenomic-guided antidepressant prescribing in patients with depression: an umbrella review and updated meta-analysis

Kiflu Tesfamicael, R. Fernández-Rodríguez, Thomas M. Polasek, 2024, Frontiers in Psychiatry.

Arti fi cial Intelligence and Machine Learning Applied at the Point of Care

Billy Amzal, Anthe S. Zandvliet, Thomas Kerbusch, 2022 .